These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Scintigraphic evaluation of primary bone tumors. Comparison of technetium-99m phosphonate and gallium citrate imaging. Simon MA, Kirchner PT. J Bone Joint Surg Am; 1980 Jul; 62(5):758-64. PubMed ID: 6446566 [Abstract] [Full Text] [Related]
3. Detection of a brain metastasis from osteosarcoma with 99mTc-methylene diphosphonate bone scanning. Ozarda AT, Legaspi JR, Haynie TP. Eur J Nucl Med; 1983 Jul; 8(12):552-4. PubMed ID: 6230234 [Abstract] [Full Text] [Related]
4. Radionuclide bone scanning of osteosarcoma: falsely extended uptake patterns. Chew FS, Hudson TM. AJR Am J Roentgenol; 1982 Jul; 139(1):49-54. PubMed ID: 6283871 [Abstract] [Full Text] [Related]
5. The indications for and limitations of bone scintigraphy in osteogenic sarcoma: a review of 55 patients. McKillop JH, Etcubanas E, Goris ML. Cancer; 1981 Sep 01; 48(5):1133-8. PubMed ID: 6268278 [Abstract] [Full Text] [Related]
8. Thallium-201 scintigraphy in bone sarcoma: comparison with gallium-67 and technetium-MDP in the evaluation of chemotherapeutic response. Ramanna L, Waxman A, Binney G, Waxman S, Mirra J, Rosen G. J Nucl Med; 1990 May 01; 31(5):567-72. PubMed ID: 2341892 [Abstract] [Full Text] [Related]
9. Thallium-201 scintigraphy to assess effect of chemotherapy in osteosarcoma. Ohtomo K, Terui S, Yokoyama R, Abe H, Terauchi T, Maeda G, Beppu Y, Fukuma H. J Nucl Med; 1996 Sep 01; 37(9):1444-8. PubMed ID: 8790189 [Abstract] [Full Text] [Related]
12. The role of bone scintigraphy in osteogenic sarcoma. Rees CR, Siddiqui AR, duCret R. Skeletal Radiol; 1986 Dec 01; 15(5):365-7. PubMed ID: 3090705 [Abstract] [Full Text] [Related]
13. Scintigraphy with 99mTc-phosphonate and 67gallium in patients suspected of primary bone tumors. Edeling CJ. Nuklearmedizin; 1982 Aug 01; 21(4):136-9. PubMed ID: 6959075 [Abstract] [Full Text] [Related]
14. Detection of lung metastases from osteosarcoma by scintigraphy using 99mTc-methylene diphosphonate. Hoefnagel CA, Bruning PF, Cohen P, Marcuse HR, van der Schoot JB. Diagn Imaging; 1981 Aug 01; 50(5):277-84. PubMed ID: 6457735 [Abstract] [Full Text] [Related]
16. The clinical value of bone and gallium scintigraphy for soft-tissue sarcomas of the extremities. Kirchner PT, Simon MA. J Bone Joint Surg Am; 1984 Mar 01; 66(3):319-27. PubMed ID: 6230363 [Abstract] [Full Text] [Related]
17. Bone scintigraphy in chondroblastoma. Humphry A, Gilday DL, Brown RG. Radiology; 1980 Nov 01; 137(2):497-9. PubMed ID: 6449026 [Abstract] [Full Text] [Related]
18. Dynamic bone scintigraphy for evaluation of tumor response after preoperative chemotherapy. A retrospective study of osteosarcoma and Ewing's sarcoma patients. Winderen M, Stenwig AE, Solheim OP, Saeter G, Aas M. Acta Orthop Scand Suppl; 1999 Jun 01; 285():11-7. PubMed ID: 10429616 [No Abstract] [Full Text] [Related]
19. Osteogenic sarcoma with pulmonary metastasis visualized by bone imaging. Velchik MG, Wegener W. Clin Nucl Med; 1989 Sep 01; 14(9):662-5. PubMed ID: 2791421 [Abstract] [Full Text] [Related]
20. Quantitative scanning of osteogenic sarcoma with nitrogen-13-labeled L-glutamate. Gelbard AS, Benua RS, Laughlin JS, Rosen G, Reiman RE, McDonald JM. J Nucl Med; 1979 Jul 01; 20(7):782-4. PubMed ID: 295364 [Abstract] [Full Text] [Related] Page: [Next] [New Search]